Neurocrine Biosciences, Inc. NBIX
164.63 USD +4.87 (+3.05%)
At closeNov 6, 2026, 4:27 PM EST
164.63 0.00 0.00%
After hours · Nov 6, 4:27 PM ET
158.66 Day range 165.86
123.10 52-week range 185.50
- YTD
- +16.08%
- 1 year
- +6.35%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.86B | 2.36B | 1.89B | 1.49B | 1.13B | |
| 2.81B | 2.32B | 1.85B | 1.47B | 1.12B | |
| 619.10M | 570.50M | 250.90M | 249.00M | 102.50M | |
| 478.60M | 341.30M | 249.70M | 154.50M | 89.60M | |
| 4.67 | 3.29 | 2.47 | 1.56 | 0.92 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 713.00M | 233.00M | 251.10M | 262.90M | 340.80M | |
| 4.63B | 3.72B | 3.25B | 2.37B | 2.07B | |
| 1.38B | 1.13B | 1.02B | 660.90M | 698.50M | |
| 415.30M | 455.10M | 428.40M | 262.90M | 440.40M | |
| 3.25B | 2.59B | 2.23B | 1.71B | 1.37B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 782.70M | 595.40M | 389.90M | 339.40M | 256.50M | |
| -264.40M | -126.80M | -467.10M | -177.10M | -130.20M | |
| -38.30M | -486.70M | 65.30M | -234.30M | 27.40M | |
| -34.00M | -38.20M | -28.30M | -16.50M | -23.40M | |
| 480.00M | -18.10M | -11.60M | -73.30M | 153.70M |